The predictable effect that renal failure has on H2 receptor antagonists - Increasing the half-life along with increasing prescribing errors

Nephrology Dialysis Transplantation

Volumn 20, Issue 11, 2005, Pages 2315-2317

  Boudville, Neil ^a  

^a UNIVERSITY OF WESTERN AUSTRALIA   (Australia)

Author keywords

Histamine H2 antagonists; Kidney failure; Kidney failure, acute; Kidney failure, chronic; Medication errors; Pharmacokinetics

Indexed keywords

ANTIULCER AGENT; FAMOTIDINE; HISTAMINE H2 RECEPTOR ANTAGONIST; NIZATIDINE; PROTON PUMP INHIBITOR; RANITIDINE;

CLINICAL TRIAL; COST BENEFIT ANALYSIS; COST CONTROL; DRUG BLOOD LEVEL; DRUG CLEARANCE; DRUG DOSE REDUCTION; DRUG EFFICACY; DRUG HALF LIFE; EDITORIAL; HUMAN; KIDNEY DYSFUNCTION; KIDNEY FAILURE; LOW DRUG DOSE; MEDICATION ERROR; MENTAL DETERIORATION; META ANALYSIS; PRESCRIPTION; PRIORITY JOURNAL; SYSTEMATIC REVIEW;

DOSE-RESPONSE RELATIONSHIP, DRUG; HALF-LIFE; HISTAMINE H2 ANTAGONISTS; HUMANS; INJECTIONS, INTRAVENOUS; KIDNEY FAILURE; MEDICAL ERRORS; PEPTIC ULCER; PRESCRIPTIONS, DRUG; RISK FACTORS;

EID: 27644476289     PISSN: 09310509     EISSN: 14602385     Source Type: Journal    
DOI: 10.1093/ndt/gfi046     Document Type: Editorial

References (10)

1. Manlucu J, Tonelli M, Ray JG et al. Dose reducing H2 receptor antagonists in the presence of low glomerular filtration rate: A systematic review of the evidence. Nephrol Dial Transplant 2005; doi:10.1093/ndt/gfi025
2. Ostro MJ. Pharmacodynamics and pharmacokinetics of parenteral histamine (H2)-receptor antagonists. Am J Med 1987; 83: 15-22
3. Callaghan JT, Bergstrom RF, Rubin A et al. A pharmaco-kinetic profile of nizatidine in man. Scand J Gastroenterol 1987; 136 [suppl]: 9-17
4. Gladziwa U, Klotz U. Pharmacokinetics and pharmaco-dynamics of H2-receptor antagonists in patients with renal insufficiency. Clin Pharmacokinet 1993; 24: 319-332
5. Dettmer RM, Riley TH, Byfield F, Green PHR. The use of intravenous H2-receptor antagonists in a tertiary care hospital. Am J Gastroenterol 1999; 94: 3473-3477
6. von Laue NC, Schwappach DL, Koeck CM. The epidemiology if preventable adverse drug events: A review of the literature. Wien Klin Wochenschr 2003; 115: 407-415
7. Vaczek D. Top 200 drugs of 2002. Pharmacy Times 2003; April: 20-24
8. Blendon RJ, Des Roches CM, Brodie M et al. View of practicing physicians and the public on medical errors. N Eng J Med 2002; 347: 1933-1941
9. Bates DW, Gawande AA. Improving safety with information technology. N Eng J Med 2003; 348: 2526-2535
10. Chertow GM, Lee J, Kuperman GJ et al. Guided medication dosing for inpatients with renal insufficiency. JAMA 2001; 286: 2839-2844